Published in J Infect Dis on May 01, 1982
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med (1989) 2.89
Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol (1991) 1.55
Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes. J Virol (1986) 1.48
Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J Clin Invest (1982) 1.30
Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect Immun (1983) 1.09
Animal cytomegaloviruses. Microbiol Rev (1990) 1.02
Surveillance of mice for antibodies to murine cytomegalovirus. J Clin Microbiol (1986) 0.91
Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids. J Virol (1990) 0.87
Persistent humoral immune responses in the CNS limit recovery of reactivated murine cytomegalovirus. PLoS One (2012) 0.86
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science (1987) 11.14
Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 7.04
Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect Immun (1973) 5.29
Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J Virol (1988) 4.85
Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology (1990) 4.00
Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med (1995) 3.80
Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection. Nat New Biol (1972) 3.23
The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J Virol (1988) 3.22
Human herpesviruses: a consideration of the latent state. Microbiol Rev (1989) 3.15
A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology (1988) 3.11
Evidence that neurons harbor latent herpes simplex virus. Infect Immun (1974) 3.03
Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med (1989) 2.77
Latent herpes simplex virus and the nervous system,. Curr Top Microbiol Immunol (1975) 2.71
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis (1995) 2.65
Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc Natl Acad Sci U S A (1982) 2.65
Restriction of herpes simplex virus by macrophages. An analysis of the cell-virus interaction. J Exp Med (1971) 2.61
Latent herpes simplex virus in the central nervous system of rabbits and mice. J Exp Med (1973) 2.48
Functional and molecular analyses of the avirulent wild-type herpes simplex virus type 1 strain KOS. J Virol (1986) 2.41
Molecular analysis of herpes simplex virus type 1 during epinephrine-induced reactivation of latently infected rabbits in vivo. J Virol (1994) 2.41
Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus. J Virol (1975) 2.40
Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother (1991) 2.40
Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology (1983) 2.32
Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J Virol (1994) 2.27
Latent infection and the elusive cytomegalovirus. Rev Infect Dis (1983) 2.24
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology (1983) 2.19
Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest (1988) 2.05
Replication of varicella-zoste virus in cell culture: an ultrastructural study. J Ultrastruct Res (1970) 1.99
A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol (1996) 1.94
Maintenance of latent herpetic infection: an apparent role for anti-viral IgG. J Immunol (1974) 1.91
Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons. J Virol (1989) 1.85
Association of cervical cytomegaloviruses with venereal disease. N Engl J Med (1973) 1.84
Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. JAMA (1987) 1.84
Two colinear and spliced viral transcripts are present in non-virus-producing benign and malignant neoplasms induced by the shope (rabbit) papilloma virus. J Virol (1982) 1.83
Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology (1992) 1.81
Pathogenesis of herpetic encephalitis in mice after ophthalmic inoculation. J Infect Dis (1974) 1.80
Immunosuppression reactivates and disseminates latent murine cytomegalovirus. J Gen Virol (1977) 1.79
Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med (1988) 1.75
Latency competence of thirteen HSV-1 temperature-sensitive mutants. J Gen Virol (1980) 1.75
Clinical pharmacology of carbenicillin compared with other penicillins. J Infect Dis (1970) 1.68
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J Clin Invest (1992) 1.62
Changes in nuclear basic proteins during pseudorabies virus infection. J Virol (1969) 1.60
The effect of pregnancy and menstruation on the size of the spleen. J Physiol (1928) 1.58
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol (1991) 1.55
Temperature-sensitive mutants of herpes simplex virus differ in the capacity to establish latent infections in mice. Virology (1977) 1.54
Nature of the scrapie agent: evidence against a viroid. J Virol (1974) 1.48
Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology (1993) 1.48
Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol (2005) 1.48
Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection. Arch Ophthalmol (1972) 1.48
Demographic and dietary determinants of constipation in the US population. Am J Public Health (1990) 1.47
Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med (1992) 1.47
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res (2001) 1.44
Latent herpetic infections following experimental viraemia. J Gen Virol (1976) 1.44
Modification by adoptive humoral immunity of murine cytomegalovirus infection. J Infect Dis (1981) 1.43
Cytomegalovirus viremia detected by molecular hybridization and electron microscopy. Ann Intern Med (1984) 1.43
Left ventricular unloading during reperfusion does not limit myocardial infarct size. Circulation (1990) 1.43
Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence. J Virol (1987) 1.40
Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science (1986) 1.40
Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40
Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb Pathog (1987) 1.39
Multiple copies of Shope virus DNA are present in cells of benign and malignant non-virus-producing neoplasms. J Virol (1979) 1.39
Molecular and biological characterization of a herpes simplex virus type 1 (HSV-1) neuroinvasiveness gene. J Exp Med (1990) 1.36
Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus. Infect Immun (1978) 1.34
Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus. J Clin Invest (1982) 1.30
Pathogenesis of reactivated latent murine cytomegalovirus infection. Am J Pathol (1979) 1.28
Clinical aspects of CNS cysticercosis. Arch Intern Med (1980) 1.27
A major portion of the latent pseudorabies virus genome is transcribed in trigeminal ganglia of pigs. J Virol (1990) 1.25
The herpes simplex virus type 1 reactivation function lies outside the latency-associated transcript open reading frame ORF-2. J Virol (1993) 1.25
Latent infections in spinal ganglia with thymidine kinase-deficient herpes simplex virus. J Virol (1989) 1.25
Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol (1994) 1.24
Latent infections induced by herpes simplex viruses. Cancer Res (1973) 1.20
Acute infection of differentiated neuroblastoma cells by latency-positive and latency-negative herpes simplex virus ts mutants. Virology (1979) 1.18
Latent characteristics of selected herpesviruses. Adv Cancer Res (1978) 1.18
Detection of latent cytomegalovirus DNA in diverse organs of mice. J Infect Dis (1993) 1.15
Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology (1983) 1.14
Labile coat: reason for noninfectious cell-free varicella-zoster virus in culture. J Virol (1968) 1.13
Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response. J Immunol (1996) 1.12
Decreased reporter gene expression during latent infection with HSV LAT promoter constructs. Virology (1993) 1.12
Lethal infection with murine cytomegalovirus after early viral replication in the spleen. J Infect Dis (1983) 1.12
Restriction of herpes simplex virus replication by poliovirus: a selective inhibition of viral translation. Virology (1972) 1.12
Molecular and biological characterization of a type 1 herpes simplex virus (HSV-1) specifically deleted for expression of the latency-associated transcript (LAT). Microb Pathog (1989) 1.11
Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis (1996) 1.11
Clinical pharmacology of pivampicillin as compared with ampicillin. Antimicrob Agents Chemother (Bethesda) (1970) 1.11
Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. Virology (1994) 1.10
Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (1995) 1.10
Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect Immun (1983) 1.09
Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains. J Virol (1988) 1.08
Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system. J Virol Methods (1995) 1.07
Glycoprotein B is a specific determinant of herpes simplex virus type 1 neuroinvasiveness. J Virol (1993) 1.06
Neuron-specific restriction of a herpes simplex virus recombinant maps to the UL5 gene. J Virol (1994) 1.06
Bordetella bronchiseptica bacteremia. West J Med (1984) 1.06
Localization of a herpes simplex virus neurovirulence gene dissociated from high-titer virus replication in the brain. J Virol (1988) 1.04
Biological basis for virulence of three strains of herpes simplex virus type 1. J Gen Virol (1987) 1.04